October 2016 FDA Recall Drug by Amerisource Health Services
D-0137-2017 - Failed Dissolution Specifications

This Class III drug recall was voluntarily initiated by Amerisource Health Services on October 27, 2016 for the product Drug. The FDA reported the reason for recall as failed dissolution specifications. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0137-2017

Reason for Recall
Failed Dissolution Specifications: The firm was notified that there was a dissolution out of specification result on the 6 month stability samples.
Initiated
10-27-2016
Reported
11-23-2016
Quantity
a) 15,409 bottles b) 5,128 bottles

Recall Profile & Regulatory Data

Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Amerisource Health Services
Nationwide and Puerto Rico
Bupropion Hydrochloride Extended-Release Tablets, USP (XL), 300 mg, a) 90-count bottle (NDC 68001-264-05), b) 500-count bottle (NDC 68001-264-03) , Rx only, Manufactured by: Cadila Healthcare Limited, Ahmedabad, India For BluePoint Laboratories

Batch or Lot Expiration Information

Lot# : a) M601509, Exp 3/31/2018; M606506, Exp 4/30/2018; b) M601510, Exp 3/31/2018; M604444, Exp 4/30/2018; M606515, Exp 4/30/2018.